These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
399 related items for PubMed ID: 12140029
1. Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Holekamp NM, Bouck N, Volpert O. Am J Ophthalmol; 2002 Aug; 134(2):220-7. PubMed ID: 12140029 [Abstract] [Full Text] [Related]
2. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP, Lam DS. Am J Ophthalmol; 2006 Mar; 141(3):456-62. PubMed ID: 16490490 [Abstract] [Full Text] [Related]
3. Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia. Chan WM, Lai TY, Chan KP, Li H, Liu DT, Lam DS, Pang CP. Retina; 2008 Oct; 28(9):1308-13. PubMed ID: 18728623 [Abstract] [Full Text] [Related]
4. Changes in aqueous vascular endothelial growth factor and pigment epithelium-derived factor after ranibizumab alone or combined with verteporfin for exudative age-related macular degeneration. Ahn JK, Moon HJ. Am J Ophthalmol; 2009 Nov; 148(5):718-724.e1. PubMed ID: 19674731 [Abstract] [Full Text] [Related]
5. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Bhutto IA, McLeod DS, Hasegawa T, Kim SY, Merges C, Tong P, Lutty GA. Exp Eye Res; 2006 Jan; 82(1):99-110. PubMed ID: 16019000 [Abstract] [Full Text] [Related]
6. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Duh EJ, Yang HS, Haller JA, De Juan E, Humayun MS, Gehlbach P, Melia M, Pieramici D, Harlan JB, Campochiaro PA, Zack DJ. Am J Ophthalmol; 2004 Apr; 137(4):668-74. PubMed ID: 15059706 [Abstract] [Full Text] [Related]
7. Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy. Tatar O, Adam A, Shinoda K, Stalmans P, Eckardt C, Lüke M, Bartz-Schmidt KU, Grisanti S. Am J Ophthalmol; 2006 Jul; 142(1):95-104. PubMed ID: 16815256 [Abstract] [Full Text] [Related]
8. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H. Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666 [Abstract] [Full Text] [Related]
9. Vitreous levels of proteins implicated in angiogenesis are modulated in patients with retinal or choroidal neovascularization. Huber M, Wachtlin J. Ophthalmologica; 2012 Nov; 228(3):188-93. PubMed ID: 22868384 [Abstract] [Full Text] [Related]
10. PEDF expression affects the oxidative and inflammatory state of choroidal endothelial cells. Farnoodian M, Sorenson CM, Sheibani N. Am J Physiol Cell Physiol; 2018 Apr 01; 314(4):C456-C472. PubMed ID: 29351407 [Abstract] [Full Text] [Related]
11. Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation. Costagliola C, Semeraro F, dell'Omo R, Romano MR, Russo A, Aceto F, Mastropasqua R, Porcellini A. Br J Ophthalmol; 2015 Jul 01; 99(7):1004-8. PubMed ID: 25770144 [Abstract] [Full Text] [Related]
12. [Molecular mechanism for choroidal neovascularization in age-related macular degeneration]. Ohno-Matsui K. Nippon Ganka Gakkai Zasshi; 2003 Nov 01; 107(11):657-73. PubMed ID: 14661539 [Abstract] [Full Text] [Related]
13. Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD. Pons M, Marin-Castaño ME. Invest Ophthalmol Vis Sci; 2011 Jun 01; 52(6):3842-53. PubMed ID: 21330654 [Abstract] [Full Text] [Related]
14. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. Ohno-Matsui K, Morita I, Tombran-Tink J, Mrazek D, Onodera M, Uetama T, Hayano M, Murota SI, Mochizuki M. J Cell Physiol; 2001 Dec 01; 189(3):323-33. PubMed ID: 11748590 [Abstract] [Full Text] [Related]
15. Cigarette smoke-related hydroquinone dysregulates MCP-1, VEGF and PEDF expression in retinal pigment epithelium in vitro and in vivo. Pons M, Marin-Castaño ME. PLoS One; 2011 Feb 28; 6(2):e16722. PubMed ID: 21386905 [Abstract] [Full Text] [Related]
16. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M. Am J Ophthalmol; 2002 Sep 28; 134(3):348-53. PubMed ID: 12208245 [Abstract] [Full Text] [Related]
17. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy. Zheng B, Li T, Chen H, Xu X, Zheng Z. Am J Ophthalmol; 2011 Dec 28; 152(6):1039-43. PubMed ID: 21851923 [Abstract] [Full Text] [Related]
18. [Molecular mechanism of choroidal neovascularization in age-related macular degeneration]. Yoshida T. Nippon Ganka Gakkai Zasshi; 2007 Nov 28; 111(11):881-91. PubMed ID: 18051818 [Abstract] [Full Text] [Related]
19. Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema. Noma H, Funatsu H, Mimura T, Harino S, Eguchi S, Hori S. Graefes Arch Clin Exp Ophthalmol; 2010 Nov 28; 248(11):1559-65. PubMed ID: 20714746 [Abstract] [Full Text] [Related]
20. Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization. Zhu Q, Ziemssen F, Henke-Fahle S, Tatar O, Szurman P, Aisenbrey S, Schneiderhan-Marra N, Xu X, Tübingen Bevacizumab Study Group, Grisanti S. Ophthalmology; 2008 Oct 28; 115(10):1750-5, 1755.e1. PubMed ID: 18708261 [Abstract] [Full Text] [Related] Page: [Next] [New Search]